
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Marcel van den Brink discloses the following relationships and financial interests:
-
Ceramedix
Provision of Services -
DKMS
Fiduciary Role/Position; Provision of Services -
Da Volterra
Provision of Services -
Garuda Therapeutics
Provision of Services -
GlaxoSmithKline
Provision of Services -
Juno Therapeutics
Intellectual Property Rights -
LyGenesis, Inc.
Provision of Services
-
MJH Life Sciences
Provision of Services -
Pluto Immunotherapeutics
Ownership / Equity Interests; Provision of Services -
Rheos Medicines, Inc
Provision of Services -
Seres Therapeutics
Intellectual Property Rights; Ownership / Equity Interests; Provision of Services -
Smart Immune SAS
Provision of Services (uncompensated) -
ThymoFox, Inc.
Ownership / Equity Interests -
WindMIL Therapeutics, Inc.
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures